News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
276,265 Results
Type
Article (14524)
Company Profile (282)
Press Release (261459)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (81351)
Career Advice (154)
Deals (13749)
Drug Delivery (35)
Drug Development (50821)
Employer Resources (31)
FDA (5875)
Job Trends (5191)
News (147463)
Policy (10323)
Tag
Academia (923)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (22585)
ALS (69)
Alzheimer's disease (852)
Antibody-drug conjugate (ADC) (108)
Approvals (5899)
Artificial intelligence (133)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4592)
BIOSECURE Act (6)
Biosimilars (46)
Biotechnology (232)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (168)
Cancer (1527)
Cardiovascular disease (120)
Career advice (135)
Career pathing (2)
CAR-T (121)
Cell therapy (340)
Cervical cancer (9)
Clinical research (41473)
Collaboration (569)
Compensation (281)
Complete response letters (13)
COVID-19 (1040)
CRISPR (44)
C-suite (171)
Cystic fibrosis (77)
Data (1599)
Denatured (11)
Depression (32)
Diabetes (143)
Diagnostics (1392)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (29)
Drug shortages (4)
Duchenne muscular dystrophy (91)
Earnings (30470)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (49317)
Executive appointments (473)
FDA (6648)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (513)
Gene editing (102)
Generative AI (10)
Gene therapy (261)
GLP-1 (371)
Government (1092)
Grass and pollen (2)
Guidances (66)
Healthcare (6720)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (97)
Indications (20)
Infectious disease (1106)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (70)
Interviews (19)
IPO (7354)
IRA (11)
Job creations (885)
Job search strategy (128)
Kidney cancer (7)
Labor market (8)
Layoffs (214)
Leadership (3)
Legal (1499)
Liver cancer (34)
Lung cancer (207)
Lymphoma (104)
Machine learning (5)
Management (7)
Manufacturing (153)
MASH (59)
Medical device (2759)
Medtech (2760)
Mergers & acquisitions (6736)
Metabolic disorders (404)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (71)
Neuropsychiatric disorders (25)
Neuroscience (1272)
NextGen: Class of 2025 (2044)
Non-profit (853)
Now hiring (22)
Obesity (198)
Opinion (102)
Ovarian cancer (66)
Pain (46)
Pancreatic cancer (60)
Parkinson's disease (121)
Partnered (8)
Patents (136)
Patient recruitment (82)
Peanut (35)
People (26054)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14620)
Phase II (19289)
Phase III (12193)
Pipeline (921)
Policy (48)
Postmarket research (873)
Preclinical (6180)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (298)
Real estate (1510)
Recruiting (12)
Regulatory (8856)
Reports (16)
Research institute (950)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (62)
Series A (100)
Series B (66)
Service/supplier (2)
Sickle cell disease (41)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (2008)
State (1)
Stomach cancer (4)
Supply chain (24)
Tariffs (12)
The Weekly (37)
Vaccines (217)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Last 7 days (560)
Last 30 days (1738)
Last 365 days (19424)
2025 (6970)
2024 (20738)
2023 (22681)
2022 (27896)
2021 (28771)
2020 (24038)
2019 (16582)
2018 (11992)
2017 (14106)
2016 (12131)
2015 (14803)
2014 (10725)
2013 (7753)
2012 (7878)
2011 (7943)
2010 (7696)
Location
Africa (149)
Alabama (43)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17642)
Australia (3009)
California (4047)
Canada (1184)
China (372)
Colorado (152)
Connecticut (154)
Delaware (110)
Europe (40338)
Florida (494)
Georgia (121)
Idaho (17)
Illinois (243)
India (10)
Indiana (94)
Iowa (2)
Japan (85)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (496)
Massachusetts (3220)
Michigan (76)
Minnesota (150)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1005)
New Mexico (12)
New York (1083)
North Carolina (571)
North Dakota (5)
Northern California (1802)
Ohio (114)
Oklahoma (9)
Oregon (21)
Pennsylvania (797)
Puerto Rico (6)
Rhode Island (19)
South America (215)
South Carolina (5)
Southern California (1554)
Tennessee (25)
Texas (471)
United States (13872)
Utah (60)
Virginia (83)
Washington D.C. (31)
Washington State (359)
Wisconsin (16)
276,265 Results for "topas therapeutics gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Topas Therapeutics’ TPM502 Achieves Gluten-specific Tolerance Induction, Positive Safety Profile in Phase 2a Trial in Celiac Disease Patients
May 7, 2025
·
6 min read
Press Releases
Topas Therapeutics Announces Presentation of Phase 2a Data for TPM502 in Celiac Disease at Digestive Disease Week® 2025 in San Diego
April 25, 2025
·
2 min read
Press Releases
Topas Therapeutics Publishes Foundational Data Demonstrating Tolerance Induction by its Proprietary Nanoparticle Platform in Frontiers in Immunology
March 17, 2025
·
3 min read
Business
Topas Therapeutics Appoints Hugo Fry as CEO
Topas Therapeutics, a clinical-stage biotech company developing novel antigen-specific immune tolerance therapies to treat autoimmune disorders, announced the appointment of Hugo Fry as its new Chief Executive Officer.
May 7, 2024
·
3 min read
Press Releases
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
April 22, 2025
·
6 min read
Press Releases
Topas Therapeutics Announces Positive Topline Results from Phase 2a Trial Evaluating TPM502 in Patients with Celiac Disease
October 15, 2024
·
3 min read
Press Releases
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
March 19, 2025
·
1 min read
Press Releases
T-CURX GmbH Enters into Technology Access Agreement with Kytopen
February 14, 2025
·
5 min read
Press Releases
Gift of Life Biologics and Cellex Cell Professionals GmbH Celebrate Successful Partnership to Deliver High-Quality Starting Materials for Final Drug Product Manufacturing in Cell and Gene Therapy
April 8, 2025
·
4 min read
Press Releases
Swarm Oncology Ltd. and Cellex Cell Professionals GmbH Announce Strategic Partnership to Advance Swarm’s Innovative T Cell Therapies for Solid Cancers
February 25, 2025
·
3 min read
1 of 27,627
Next
